Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

December 3, 2018 Issue

09648-cover1-pills-hero.jpg

December 3, 2018 Cover

Volume 96, Issue 48

Cutting-edge science led to therapeutic breakthroughs and a flood of investment in an eventful 2018

Credit: Yang H. Ku/C&EN/Shutterstock

Full Article
Volume 96 | Issue 48

All Issues

Quote of the Week

“Every fraction of a degree matters.”

Rachel Cleetus, policy director , Union of Concerned Scientists’ climate and energy program

C&EN’s Year in Pharma 2018

Cutting-edge science led to therapeutic breakthroughs and a flood of investment in an eventful 2018

  • Civica Rx aims to shake up the generics market

    Started by hospitals, the new nonprofit will tackle drug shortages and spiking prices for older drugs 

  • Teaching chemistry students to use the labs of the future

    Educators want to prepare chemists for a time when autonomous machines will do the work

ADVERTISEMENT
image name
Policy

As claims of CRISPR use in first gene-edited babies emerge, scientists and ethicists respond

Chinese researcher He Jiankui announced that he used CRISPR to install HIV resistance in embryos, leading to the birth of twin girls. Another pregnancy may be underway

ADVERTISEMENT
ADVERTISEMENT